SEC Form 4 · accession 0001415889-18-001024
Sensus Healthcare, Inc. · SRTS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Joseph C Sardano
Officer — CHIEF EXECUTIVE OFFICER · Director
Period of report
Jun 21, 2018
Accepted (ET)
Jun 25, 2018 · 7:20 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001494891
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF2 | Jun 21, 2018 | S | 4,865 | $7.52 | D | 1,561,174 | D | |
| Common StockF4 | Jun 25, 2018 | S | 10,854 | $7.52 | D | 1,550,320 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person in November 2017.
- F2The price reported is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $7.50 to $7.60. The reporting person undertakes to provide to Sensus Healthcare, Inc., any security holder of Sensus Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Form 4.
- F3The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person in November 2017.
- F4The price reported is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $7.50 to $7.57. The reporting person undertakes to provide to Sensus Healthcare, Inc., any security holder of Sensus Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Form 4.